Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center
Head & Neck · 2025
DOI: 10.1002/hed.28139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Mete Gundog und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Erciyes University, Kayseri, Turkey. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Glottis, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In recent years, smaller‐volume radiotherapy has attracted attention. It appears to be a safe and effective treatment for glottic laryngeal cancer. This study evaluated the results of ultra‐hypofractionated radiotherapy for early glottic laryngeal cancer in unfit patients.
Methods
This retrospective study analyzed 22 patients diagnosed with early glottic cancer between June 2017 and January 2021. The involved vocal cord was treated with 35–42.5 Gy in 5 fractions.
Results
On a 59‐month median follow‐up, the 5‐year overall survival and local control rate were 68.2% and 94.7%, respectively. However, the 5‐year larynx preservation rate was 89.7%. Chondronecrosis was observed in one patient (4.5%), and soft tissue necrosis in one patient (4.5%). PTV D98 (> 41.08 Gy) was found to be statistically significant in surgery‐needed events (HR: 22.4, 95% CI: 1.9–252.1, p = 0.01).
Conclusion
Single‐cord ultra‐hypofractionated radiotherapy appears to be an effective treatment for local control. However, the risk of radionecrosis is higher at doses above 41.08 Gy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Erciyes University, Kayseri, Turkey.
ORCID-Profile: Mete Gundog, Esin Kiraz
Zitieren
APA
Gundog, M., & Kiraz, E. (2025). Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center. Head & Neck. https://doi.org/10.1002/hed.28139
Vancouver
Gundog M, Kiraz E. Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center. Head & Neck. 2025. doi:10.1002/hed.28139
BibTeX
@article{Gundog2025,
author = {Gundog, Mete and Kiraz, Esin},
title = {Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28139}
}
EUVIMED